During the past decade, Yale Eye Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Yale Eye Center" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Yale Eye Center" are "Anterior Uveitis" (1 trials), "Diabetic Macular Edema" (1 trials), "Glaucoma" (1 trials), "Intraocular Pressure" (1 trials) and "Intravitreal Injections" (1 trials). Many other conditions were trialed in "Yale Eye Center" in a lesser frequency.

Most popular intervention types in "Yale Eye Center" are "Drug" (3 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "100 mM sodium citrate buffer solution" (1 trials), "40 mg/mL Dexamethasone phosphate ophthalmic solution" (1 trials), "Dynamic contour tonometry" (1 trials), "Laser photocoagulation" (1 trials) and "Latanoprost 0.005%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Yale Eye Center" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Yale Eye Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Yale Eye Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Yale Eye Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".